Vista Partners Updates Coverage on Mast Therapeutics, Inc. (NYSE MKT: MSTX); Price Target $2.25

[Marketwired] – Vista Partners announced today that it has updated coverage on Mast Therapeutics Inc. , a publicly traded biopharmaceutical company headquartered in San Diego, CA; and maintains its twelve-month price … more

View todays social media effects on MSTX

View the latest stocks trending across Twitter. Click to view dashboard

See who Mast is hiring next, click here to view